Extracorporeal shock wave therapy in the management of midsubstance achilles tendinopathy: The ASSERT database
Articolo
Data di Pubblicazione:
2018
Citazione:
Extracorporeal shock wave therapy in the management of midsubstance achilles tendinopathy: The ASSERT database / G. Maffulli, J. Padulo, E. Iuliano, A. Saxena, J. Rompe, N. Maffulli. - In: M.L.T.J. MUSCLES, LIGAMENTS AND TENDONS JOURNAL. - ISSN 2240-4554. - 8:3(2018 Sep), pp. 409-415. [10.11138/mltj/2018.8.3.402]
Abstract:
Introduction: The present study aimed to determine the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) in patients suffering from midsubstance Achilles tendinopathy in both the short and middle term.
Methods: Participants were recruited by different clinicians in the National Health Service (NHS) and private sector centres in the UK. All data were collected in a web-based database named ASSERT (Assessment of the Effectiveness of ESWT for Soft Tissue Injuries). The 84 participants (average age 54.30 y; range 23-77 y) were administered in a standardized ESWT protocol, and outcome measures relative to their specific condition and health status (VAS for pain perception, the VISA-A for the severity of the Achilles tendinopathy in daily life activities, and the 6 scores ofEuroQol 5D for quality of life) were collected at baseline, and again after 3, 6, 12 and 24 months following ESWT intervention.
Results: There was a significant amelioration over time in 5 of the 8 analyzed outcomes (all with p <0.0001), namely VAS, VISA-A, and 3 EQ-5D domains (Mobility, Pain/Discomfort, and Usual Activities scores).
Conclusion: ESWT showed beneficial effects on midsubstance Achilles tendinopathy over a 24 month follow-up period. Level of evidence: IV.
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
G. Maffulli, J. Padulo, E. Iuliano, A. Saxena, J. Rompe, N. Maffulli
Link alla scheda completa: